APA (7th ed.) Citation

Crabb, S., Dempsey, L., Soulis, E., Hinsley, S., Song, Y., Barber, J., . . . Tapper, W. (2022). 1772P Characterisation of a DNA repair deficiency (DRD) biomarker phenotype in metastatic urothelial carcinoma (mUC) within the ATLANTIS clinical trial platform. Annals of Oncology, 33, S1348. https://doi.org/10.1016/j.annonc.2022.07.1850

Chicago Style (17th ed.) Citation

Crabb, S.J, et al. "1772P Characterisation of a DNA Repair Deficiency (DRD) Biomarker Phenotype in Metastatic Urothelial Carcinoma (mUC) Within the ATLANTIS Clinical Trial Platform." Annals of Oncology 33 (2022): S1348. https://doi.org/10.1016/j.annonc.2022.07.1850.

MLA (9th ed.) Citation

Crabb, S.J, et al. "1772P Characterisation of a DNA Repair Deficiency (DRD) Biomarker Phenotype in Metastatic Urothelial Carcinoma (mUC) Within the ATLANTIS Clinical Trial Platform." Annals of Oncology, vol. 33, 2022, p. S1348, https://doi.org/10.1016/j.annonc.2022.07.1850.